Archive: 2017-2018 | 2016 | 2015 | 2014 


MCRI Helps FDA with Drug Safety Monitoring (April 2018)
Center for Clinical Epidemiology and Population Health (CCEPH) Epidemiologist Robert Greenlee, PhD, MPH, was recently quoted in an AMA Wire article about the FDA Sentinel System to monitor drug safety. Marshfield Clinic Research Institute (MCRI) is one of the 17 participating organizations and Dr. Greenlee noted that each site keeps their own data behind a local firewall to protect patient privacy.

STAT News Interviews CCEPH Director Regarding FDA's Research Findings on Flu Vaccine Effectiveness (March 2018)

Center for Clinical Epidemiology and Population Health (CCEPH) Director Edward Belongia, MD, commented on cell-culture versus egg-based flu vaccine effectiveness.

Senior CCEPH Research Scientist/Director Discusses the H3N2 Strain (February 2018)
Edward Belongia, MD, spoke with FiveThirtyEight about lower vaccine protection against the H3N2 strain and the possible impacts of antigenic imprinting, repeated vaccination, and egg-induced adaptations.

CCEPH Director and ACIP Member Votes on Reinstatement of FluMist (February 2018)
At the February 2018 Advisory Committee on Immunization Practices (ACIP) meeting, the committee voted in favor of including the live attenuated influence vaccine (LAIV) as an option for influenza vaccination in the 2018-19 season. MedPage Today covered the meeting and included a quote from Edward Belongia, MD, stressing the importance of making decisions regarding vaccine recommendations based on the best science currently available.

CCEPH Director Comments on Flu Vaccine Protection Against H3N2 (February 2018)
Center for Clinical Epidemiology and Population Health (CCEPH) Director Edward Belongia, MD, discussed flu vaccine effectiveness during H3N2 seasons with Vox News and Star Tribune.

Marshfield Clinic Contributes to National Mid-Season Flu Vaccine Effectiveness Estimates (February 2018)

On February 15, 2018, Centers for Disease Control and Prevention (CDC) published the 2017-18 interim, or mid-season, estimate of influenza vaccine effectiveness (VE) based on enrollments at Marshfield Clinic and 4 other U.S. sites. These estimates are used to guide next season vaccine strain selection, additional flu vaccine research and policy recommendations.

CIDRAP Interviews CCEPH Director on Canadian Flu Vaccine Effectiveness Estimates (February 2018)
Center for Clinical Epidemiology and Population Health (CCEPH) Edward Belongia, MD, discussed the possible impacts of egg-induced adaptations and antigenic imprinting on low H3N2 performance.

Vox Interviews CCEPH Director About the H3N2 Flu Virus (February 2018)

Center for Clinical Epidemiology and Population Health (CCEPH) Edward Belongia, MD, was interviewed by Vox on vaccine effectiveness during H3N2 flu seasons. 

CCEPH Director Discusses the H3N2 Flu Virus with STAT News (January 2018)

In an interview with STAT News, Center for Clinical Epidemiology and Population Health (CCEPH) Director Edward Belongia, MD, commented on reasons the H3N2 flu virus may cause more severe illness and death than other flu viruses that infect people. 

CCEPH Scientist Interviewed on Preventing Falls from Tree Stands During Hunting Season (November 2017)

Jeffrey VanWormer, PhD spoke with RFD Radio in November to warn hunters about the risk of falls from tree stands. RFD is a Farm Bureau Network with more than 80 stations in Illinois. Dr. VanWormer previously published a study on tree stand falls in central Wisconsin. During the radio interview, he noted that hunting injuries tend to be serious and a cell phone is often the only way to get out of the woods.

CCEPH Researcher Interviewed by Minneapolis Star Tribune on Hazards of Deer Stands (November 2017)

Jeffrey VanWormer, PhD published a study last year describing five years of tree stand fall injuries in central Wisconsin. This caught the attention of a Minneapolis Star Tribune reporter writing about a Minnesota hunter who slipped from a deer stand and fractured his spine. In the article, Dr. VanWormer discussed the long-term risk of fall-related injuries in hunters, the contribution of alcohol, and the more frequent occurrence of fall-related injuries in bow hunters. 

What You Need to Know About the New Shingles Vaccine (October 2017)
Edward Belongia, MD, recently spoke with the Washington Post regarding a new vaccine to prevent shingles that was recently licensed by the Food and Drug Administration (FDA) and recommended by the CDC (Centers for Disease Control and Prevention) Advisory Committee on Immunization Practices (ACIP).  He serves as Chair of the ACIP Herpes Zoster Work Group which has been evaluating the new vaccine (Shingrix) and the previously licensed vaccine (Zostavax) over the past two years.

CCEPH Scientists Present Research at IDWeek (October 2017)
Huong McLean, PhD, MPH and Jennifer King, MPH presented findings from recent studies on influenza and measles, mumps, rubella (MMR) vaccine at IDWeek in San Diego, CA, October 4-8, 2017. 

Marshfield Flu Study Published in New England Journal of Medicine (August 2017)
Center for Clinical Epidemiology and Population Health (CCEPH) Scientists Ed Belongia, MD, and Huong McLean, PhD, MPH were coauthors on the research article "Influenza Vaccine Effectiveness in the United States during the 2015-16 Season" that was included in the August 10 issue of the New England Journal of Medicine.

CCEPH Scientists Present Research at SER (June 2017)
Center for Clinical Epidemiology and Population Health (CCEPH) Scientists Huong McLean, PhD, MPH and Elizabeth Vickers, MPH, attended and presented their research at the 50th Society for Epidemiologic Research (SER) meeting in Seattle, Washington, June 20-23, 2017.

MCRI Scientists and Staff Present at the Annual Vaccine Safety Datalink Meeting (May 2017)
The Marshfield Clinic Research Institute (MCRI) Vaccine Safety Datalink (VSD) Team attended and presented at the annual VSD meeting in Oakland, CA, May 23-24, 2017.

CCEPH Director Discusses Participation in the Flu VE Network with WSAW News (March 2017)
Ed Belongia, MD discussed MCRI's participation in the U.S. Flu VE Network with Channel 7 News (WSAW).  In the interview, Dr. Belongia informed viewers that by being one of five sites in the U.S. funded to conduct vaccine effectiveness each year, Marshfield Clinic contributes research results which assist the World Health Organization (WHO) in selecting flu strains for the following year's vaccine.  The interview is available for viewing on the WSAW's website.

2017 Health Care Systems Research Network 23rd Annual Conference (March 2017)
Center for Clinical Epidemiology and Population Health (CCEPH) researchers and staff were among the nearly 400 attendees at the 2017 Health Care Systems Research Network (HCSRN) Annual Conference held in San Diego, CA, March 21-23, 2017.

National Lung Screening Trial Presented at 2017 AAPM Spring Clinical Meeting (March 2017)
Center for Clinical Epidemiology and Population Health (CCEPH) Scientist Robert Greenlee, PhD, MPH, is the Principal Investigator for the National Lung Screening Trial that was presented at the 2017 American Association of Physicists in Medicine (AAPM) Spring Clinical meeting in New Orleans, March 18-21, 2017.